SEARCH

SEARCH BY CITATION

References

  • Batchelor M. and Schenk J. O. (1998) Protein kinase A activity may kinetically upregulate the striatal transporter for dopamine. J. Neurosci. 18, 1030410309.
  • Beckstead R. M., Domesick V. B. and Nauta W. J. (1979) Efferent connections of the substantia nigra and ventral tegmental area in the rat. Brain Res. 175, 191217.
  • Blanchard V., Raisman-Vozari R., Vyas S., Michel P. P., Javoy-Agid F., Uhl G. and Agid Y. (1994) Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalon. Brain Res. Mol. Brain Res. 22, 2938.
  • Calipari E. S., Huggins K. N., Mathews T. A. and Jones S. R. (2012) Conserved dorsal-ventral gradient of dopamine release and uptake rate in mice, rats and rhesus macaques. Neurochem. Int. 61, 986991.
  • Calipari E. S., Ferris M. J., Salahpour A., Caron M. G. and Jones S. R. (2013) Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression. Nat. Commun. 4, 2720.
  • Carroll M. E. and Lac S. T. (1997) Acquisition of i.v. amphetamine and cocaine self-administration in rats as a function of dose. Psychopharmacology 129, 206214.
  • Comer S. D., Mogali S., Saccone P. A. et al. (2013) Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers. Neuropsychopharmacology 38, 24272438.
  • Coulter C. L., Happe H. K. and Murrin L. C. (1996) Postnatal development of the dopamine transporter: a quantitative autoradiographic study. Brain Res. Dev. Brain Res. 92, 172181.
  • Cragg S. J., Hille C. J. and Greenfield S. A. (2000) Dopamine release and uptake dynamics within nonhuman primate striatum in vitro. J. Neurosci. 20, 82098217.
  • Crombag H. S., Ferrario C. R. and Robinson T. E. (2008) The rate of intravenous cocaine or amphetamine delivery does not influence drug-taking and drug-seeking behavior in rats. Pharmacol. Biochem. Behav. 90, 797804.
  • Daberkow D. P., Brown H. D., Bunner K. D., Kraniotis S. A., Doellman M. A., Ragozzino M. E., Garris P. A. and Roitman M. F. (2013) Amphetamine paradoxically augments exocytotic dopamine release and phasic dopamine signals. J. Neurosci. 33, 452463.
  • Di Chiara G. and Imperato A. (1988) Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Natl Acad. Sci. USA 85, 52745278.
  • Drevets W. C., Gautier C., Price J. C., Kupfer D. J., Kinahan P. E., Grace A. A., Price J. L. and Mathis C. A. (2001) Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biol. Psychiatry 49, 8196.
  • Everitt B. J. and Robbins T. W. (2013) From the ventral to the dorsal striatum: devolving views of their roles in drug addiction. Neurosci. Biobehav. Rev. 37(9 Pt A):19461954.
  • Ferris M. J., Calipari E. S., Yorgason J. T. and Jones S. R. (2013) Examining the complex regulation and drug-induced plasticity of dopamine release and uptake using voltammetry in brain slices. ACS Chem. Neurosci. 4, 693703.
  • Fischman M. W., Schuster C. R., Resnekov L., Shick J. F., Krasnegor N. A., Fennell W. and Freedman D. X. (1976) Cardiovascular and subjective effects of intravenous cocaine administration in humans. Arch. Gen. Psychiatry 133, 983989.
  • Fleckenstein A. E., Volz T. J., Riddle E. L., Gibb J. W. and Hanson G. R. (2007) New insights into the mechanism of action of amphetamines. Annu. Rev. Pharmacol. Toxicol. 47, 681698.
  • Gabriele A. and See R. E. (2011) Lesions and reversible inactivation of the dorsolateral caudate-putamen impair cocaine-primed reinstatement to cocaine-seeking in rats. Brain Res. 1417, 2735.
  • Hernandez L., Lee F. and Hoebel B. G. (1987) Simultaneous microdialysis and amphetamine infusion in the nucleus accumbens and striatum of freely moving rats: increase in extracellular dopamine and serotonin. Brain Res. Bull. 19, 623628.
  • Hoexter M. Q., Fadel G., Felício A. C. et al. (2012) Higher striatal dopamine transporter density in PTSD: an in vivo SPECT study with [(99 m)Tc]TRODAT-1. Psychopharmacology 224, 337345.
  • Ito R., Dalley J. W., Robbins T. W. and Everitt B. J. (2002) Dopamine release in the dorsal striatum during cocaine-seeking behavior under the control of a drug-associated cue. J. Neurosci. 22, 62476253.
  • John C. E. and Jones S. R. (2007) Voltammetric characterization of the effect of monoamine uptake inhibitors and releasers on dopamine and serotonin uptake in mouse caudate-putamen and substantia nigra slices. Neuropharmacology 52, 15961605.
  • Jones S. R., Garris P. A. and Wightman R. M. (1995) Different effects of cocaine and nomifensine on dopamine uptake in the caudate-putamen and nucleus accumbens. J. Pharmacol. Exp. Ther. 274, 396403.
  • Jones S. R., Gainetdinov R. R., Wightman R. M. and Caron M. G. (1998) Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. J. Neurosci. 18, 19791986.
  • Jones S. R., Joseph J. D., Barak L. S., Caron M. G. and Wightman R. M. (1999) Dopamine neuronal transport kinetics and effects of amphetamine. J. Neurochem. 73, 24062414.
  • Kuczenski R. and Segal D. S. (1992) Differential effects of amphetamine and dopamine uptake blockers (cocaine, nomifensine) on caudate and accumbens dialysate dopamine and 3-methoxytyramine. J. Pharmacol. Exp. Ther. 262, 10851094.
  • Kuczenski R., Segal D. S. and Aizenstein M. L. (1991) Amphetamine, cocaine, and fencamfamine: relationship between locomotor and stereotypy response profiles and caudate and accumbens dopamine dynamics. J. Neurosci. 11, 27032712.
  • Madras B. K., Miller G. M. and Fischman A. J. (2005) The dopamine transporter and attention-deficit/hyperactivity disorder. Biol. Psychiatry 57, 13971409.
  • Meiergerd S. M., Patterson T. A. and Schenk J. O. (1993) D2 receptors may modulate the function of the striatal transporter for dopamine: kinetic evidence from studies in vitro and in vivo. J. Neurochem. 61, 764767.
  • Pehek E. A., Schechter M. D. and Yamamoto B. K. (1990) Effects of cathinone and amphetamine on the neurochemistry of dopamine in vivo. Neuropharmacology 29, 11711176.
  • Ramsson E. S., Covey D. P., Daberkow D. P., Litherland M. T., Juliano S. A. and Garris P. A. (2011a) Amphetamine augments action potential-dependent dopaminergic signaling in the striatum in vivo. J. Neurochem. 117, 937948.
  • Ramsson E. S., Howard C. D., Covey D. P. and Garris P. A. (2011b) High doses of amphetamine augment, rather than disrupt, exocytotic dopamine release in the dorsal and ventral striatum of the anesthetized rat. J. Neurochem. 119, 11621172.
  • Richardson N. R. and Roberts D. C. (1996) Progressive ratio schedules in drug self-administration studies in rats: a method to evaluate reinforcing efficacy. J. Neurosci. Methods 66, 111.
  • Roberts D. C. S., Koob G. F., Klonoff P. and Fibiger H. C. (1980) Extinction and recovery of cocaine self-administration following 6-hydroxydopamine lesions of the nucleus accumbens. Pharmacol. Biochem. Behav. 12, 781787.
  • Robinson E. T. and Camp D. M. (1990) Does amphetamine preferentially increase the extracellular concentration of dopamine in the mesolimbic system of freely moving rats? Neuropsychopharmacology 3, 163173.
  • Salahpour A., Ramsey A. J., Medvedev I. O. et al. (2008) Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter. Proc. Natl Acad. Sci. 105, 44054410.
  • Segal D. S. and Kuczenski R. (1992) Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens. Brain Res. 577, 351355.
  • Sharp T., Zetterström T., Ljungberg T. and Ungerstedt U. (1987) A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis. Brain Res. 401, 322330.
  • Shimada S., Kitayama S., Walther D. and Uhl G. (1992) Dopamine transporter mRNA: dense expression in ventral midbrain neurons. Brain Res. Mol. Brain Res. 13, 359362.
  • Siciliano C. A., Calipari E. S., Ferris M. J. and Jones S. R. (2014) Biphasic mechanisms of amphetamine action at the dopamine terminal. J. Neurosci., 34, 55755582.
  • South T. and Huang X. F. (2008) High-fat diet exposure increases dopamine D2 receptor and decreases dopamine transporter receptor binding density in the nucleus accumbens and caudate putamen of mice. Neurochem. Res. 33, 598605.
  • Sulzer D. (2011) How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron 69, 628649.
  • Sulzer D. and Rayport S. (1993) Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Neuron 5, 797808.
  • Sulzer D., Maidment N. T. and Rayport S. (1990) Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J. Neurochem. 60, 527535.
  • Wightman R. M., Amatore C., Engstrom R. C., Hale J. D., Kristensen E. W., Kuhr W. G. and May L. J. (1998) Real-time characterization of dopamine overflow and uptake in the rat striatum. Neuroscience 25, 513523.
  • Yeghiayan S. K., Andersen S. L. and Baldessarini R. J. (1997) Lack of effect of chronic clorgyline or selegiline on dopamine and serotonin transporters in rat caudate-putamen or nucleus accumbens septi. Neurosci. Lett. 236, 147150.
  • Yorgason J. T., España R. A. and Jones S. R. (2011) Demon Voltammetry and Analysis software: analysis of cocaine-induced alterations in dopamine signaling using multiple kinetic measures. J. Neurosci. Methods 202, 158164.
  • Zito K. A., Vickers G. and Roberts D. C. (1985) Disruption of cocaine and heroin self-administration following kainic acid lesions of the nucleus accumbens. Pharmacol. Biochem. Behav. 23, 10291036.